Related Experiment Video
Updated: Aug 29, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
Ultrafiltration in patients with hypervolemia and congestive heart failure
C Ronco1, Z Ricci, Alessandra Brendolan
1Department of Nephrology, St. Bortolo Hospital, Vicenza, Italy. cronco@goldnet.it
Insights
Continuous extracorporeal therapy, like hemofiltration, can stabilize hemodynamics in patients with myocardial dysfunction and fluid overload. This therapy optimizes fluid balance, reduces edema, and supports organ perfusion, aiding recovery.
Area of Science:
- Cardiology
- Nephrology
- Critical Care Medicine
Background:
- Fluid overload is a common complication in patients with myocardial dysfunction, leading to various clinical issues.
- Myocardial dysfunction can stem from reduced contractility, diastolic dysfunction, myocardial injury, or sepsis-induced myocardial depression.
- Optimizing fluid balance, reducing edema, and managing pre- and afterload are crucial for cardiac support.
Purpose of the Study:
- To investigate the cardiovascular effects of continuous extracorporeal therapy in patients with myocardial dysfunction and fluid overload.
- To assess the impact of hemofiltration on myocardial elastance and hemodynamic stability.
- To evaluate the role of ultrafiltration in maintaining circulatory blood volume and organ perfusion.
Main Methods:
- Continuous extracorporeal therapy, specifically hemofiltration, was employed.
- Slow continuous ultrafiltration was utilized to manage fluid balance.
- Continuous refilling of intravascular volume from the interstitium was facilitated.
Main Results:
- Hemofiltration demonstrated improvement in myocardial elastance and restoration of adequate fluid balance.
- Continuous extracorporeal therapy resulted in remarkable cardiovascular stability.
- Hemodynamic parameters including mean arterial pressure, heart rate, and systemic vascular resistance were maintained.
- Stable circulating blood volume and preserved organ perfusion were observed.
Conclusions:
- Continuous extracorporeal therapy offers significant cardiovascular support in patients with myocardial dysfunction and fluid overload.
- This therapeutic approach enhances hemodynamic stability and organ perfusion.
- It is also beneficial for renal recovery in cases of acute renal failure.
Abstract:
Fluid overload may occur in patients with myocardial dysfunction and different clinical problems. Myocoardial dysfunction may be a consequence of heart dilatation with reduced contractility, ventricular stiffness with diastolic dysfunction or the consequence of myocardial injury or circulating myocardial depressant factors as seen in sepsis. In all cases, cardiac support can be achieved by the optimization of fluid balance, the reduction in organ edema and the restoration of desirable levels of pre- and afterload. Several reports have shown that myocardial elastance can improve after hemofiltration with restoration of adequate fluid balance. In such conditions, continuous extracorporeal therapy may result in remarkable cardiovascular stability with maintenance of hemodynamic parameters, including mean arterial pressure, heart rate and systemic vascular resistance. Such stability, which is achieved through the slow continuous ultrafiltration and continuous refilling of the intravascular volume from the interstitium, enables the stability of the circulating blood volume and the preservation of organ perfusion. This is also crucial for renal recovery during acute renal failure.
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Heart Failure II: Pathophysiology

